Nobel Prize winner. UC Berkeley biochemist. Innovative Genomics Institute founder. Co-inventor of CRISPR technology.

Nobel Prize winner. Scientific and Managing Director of the Max Planck Unit for the Science of Pathogens. Co-inventor of CRISPR technology.

Gene editing pioneer. Professor of Molecular Therapeutics at UC Berkeley, Director of the CRISPR Cures Beacon at the Innovative Genomics Institute.

IGI Executive Director. Former DARPA Biotech Leader. Pioneer of greentech solutions to climate change.

Co-Founder, President, and CEO of Scribe Therapeutics

Todd R. Klaenhammer Distinguished Professor at NC State University, Editor in Chief at The CRISPR Journal, CRISPR Lab Lead

Co-Founder and Scientific Advisor of Scribe Therapeutics. Professor at UC Berkeley.

Assistant Professor of Biochemistry at the University of Zurich, Switzerland.

Head of Genome Engineering Services at Vienna BioCenter.